Nitric Oxide Inhibition Strategies

References

• Knowles RG , PalaciosM, PalmerRM, MoncadaS. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl Acad. Sci. USA86(13), 5159–5162 (1989).
   PubMed Web of Science ®Google Scholar
• Pokidyshev DA , BondarenkoNA, MalyshevIet al. [Selective inhibition of inducible NO-synthase by nonselective inhibitor]. Ross. Fiziol. Zh. Im. IM Sechenova.84(12), 1420–1427 (1998).
   PubMedGoogle Scholar
• Cauwels A . Nitric oxide in shock. Kidney Int.72(5), 557–565 (2007).
   PubMed Web of Science ®Google Scholar
• Petros A , LambG, LeoneA, MoncadaS, BennettD, VallanceP. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res.28(1), 34–39 (1994).
   PubMed Web of Science ®Google Scholar
• Lorente JA , LandinL, De PabloR, RenesE, ListeD. L-arginine pathway in the sepsis syndrome. Crit. Care Med.21(9), 1287–1295 (1993).
   PubMed Web of Science ®Google Scholar
• Lopez A , LorenteJA, SteingrubJet al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med.32(1), 21–30 (2004).
   PubMed Web of Science ®Google Scholar
• Bruch-Gerharz D , RuzickaT, Kolb-BachofenV. Nitric oxide in human skin: current status and future prospects. J. Invest. Dermatol.110(1), 1–7 (1998).
   PubMed Web of Science ®Google Scholar
• Qureshi AA , LernerLH, LernerEA. From bedside to the bench and back. Nitric oxide and the cutis. Arch. Dermatol.132(8), 889–893 (1996).
   PubMedGoogle Scholar
• Lerner LH , QureshiAA, ReddyBV, LernerEA. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J. Invest. Dermatol.114(1), 196–199 (2000).
   PubMed Web of Science ®Google Scholar
• Hoffman RA , NusslerNC, GleixnerSlet al. Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. Transplantation63(1), 94–100 (1997).
   PubMed Web of Science ®Google Scholar
• Godoy LC , AndersonCT, ChowdhuryR, TrudelLJ, WoganGN. Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin. Proc. Natl Acad. Sci. USA109(50), 20373–20378 (2012).
   PubMed Web of Science ®Google Scholar
• Olesen J , AshinaM. Emerging migraine treatments and drug targets. Trends Pharmacol. Sci.32(6), 352–359 (2011).
   PubMed Web of Science ®Google Scholar
• Li N , WorthmannH, DebM, ChenS, WeissenbornK. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage. Neurol. Res.33(5), 541–548 (2011).
   PubMed Web of Science ®Google Scholar
• Banach M , PiskorskaB, CzuczwarSj, BorowiczKK. Nitric oxide, epileptic seizures, and action of antiepileptic drugs. CNS Neurol. Disord. Drug Targets10(7), 808–819 (2011).
   PubMed Web of Science ®Google Scholar
• Jadeski LC , HumKO, ChakrabortyC, LalaPK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer86(1), 30–39 (2000).
   PubMed Web of Science ®Google Scholar
• Bonfoco E , KraincD, AnkarcronaM, NicoteraP, LiptonSA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA92(16), 7162–7166 (1995).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick B , MehibelM, CowenRl, StratfordIJ. iNOS as a therapeutic target for treatment of human tumors. Nitric Oxide19(2), 217–224 (2008).
   PubMed Web of Science ®Google Scholar
• Sullivan R , GrahamCH. Chemosensitization of cancer by nitric oxide. Curr. Pharm. Design14(11), 1113–1123 (2008).
   PubMed Web of Science ®Google Scholar
• Janatuinen T , LaaksoJ, LaaksonenRet al. Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults. Vasc. Med.8(3), 185–189 (2003).
   PubMed Web of Science ®Google Scholar
• Chen Xm , HuCp, LiYj, JiangJl. Cardiovascular risk in autoimmune disorders: role of asymmetric dimethylarginine. Eur. J. Pharmacol.696(1–3), 5–11 (2012).
   PubMed Web of Science ®Google Scholar
• Baylis C . Nitric oxide synthase derangements and hypertension in kidney disease. Curr. Opin. Nephrol. Hypertens.21(1), 1–6 (2012).
   PubMed Web of Science ®Google Scholar
• Schwedhelm E , BogerRH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat. Rev. Nephrol.7(5), 275–285 (2011).
   PubMed Web of Science ®Google Scholar
• Toutouzas K , RigaM, StefanadiE, StefanadisC. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance. Hormone Metabol. Res.40(9), 655–659 (2008).
   PubMed Web of Science ®Google Scholar
• Masuda H . Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction. Int. J. Urol.15(2), 128–134 (2008).
   PubMed Web of Science ®Google Scholar
• Macallister Rj , ParryH, KimotoMet al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol.119(8), 1533–1540 (1996).
   PubMed Web of Science ®Google Scholar
• Vallance P , CollierJ, MoncadaS. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet2(8670), 997–1000 (1989).
   PubMed Web of Science ®Google Scholar
• Alexander Jh , ReynoldsHr, StebbinsAlet al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA297(15), 1657–1666 (2007).
   PubMed Web of Science ®Google Scholar
• Russo Pa , HallidayGM. Inhibition of nitric oxide and reactive oxygen species production improves the ability of a sunscreen to protect from sunburn, immunosuppression and photocarcinogenesis. Br. J. Dermatol.155(2), 408–415 (2006).
   PubMed Web of Science ®Google Scholar
• Grover R , ZaccardelliD, ColiceG, GuntupalliK, WatsonD, VincentJL. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit. Care Med.27(5), 913–922 (1999).
   PubMed Web of Science ®Google Scholar
• London ED , KimesAS, VaupelDB. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome. NIDA Res. Monogr.147, 170–181 (1995).
   PubMedGoogle Scholar
• Avontuur JA , BoomsmaF, Van Den MeirackerAH, DE JongFH, BruiningHA. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Circulation99(2), 271–275 (1999).
   PubMed Web of Science ®Google Scholar
• Evgenov OV , SveinbjornssonB, BjertnaesLJ. Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep. Acta Anaesthesiol. Scand.45(10), 1246–1254 (2001).
   PubMed Web of Science ®Google Scholar
• Evora PR , SimonMR. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann. Allergy Asthma Immunol.99(4), 306–313 (2007).
   PubMed Web of Science ®Google Scholar
• Lenglet S , MachF, MontecuccoF. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. Expert Rev. Cardiovasc. Ther.9(12), 1519–1525 (2011).
   PubMedGoogle Scholar
• Tseng Ky , CaballeroA, DecAet al. Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism. PLoS ONE6(11), e27187 (2011).
   PubMed Web of Science ®Google Scholar
• Harbrecht BG . Therapeutic use of nitric oxide scavengers in shock and sepsis. Curr. Pharm. Design12(27), 3543–3549 (2006).
   PubMed Web of Science ®Google Scholar
• Punathil T , KatiyarSK. Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2. Mol. Carcinog.48(3), 232–242 (2009).
   PubMed Web of Science ®Google Scholar
• Durante W , JohnsonFK, JohnsonRA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharm. Physiol.34(9), 906–911 (2007).
   PubMed Web of Science ®Google Scholar
• Campbell L , SavilleCR, MurrayPJ, CruickshankSM, HardmanMJ. Local arginase 1 activity is required for cutaneous wound healing. J. Invest. Dermatol.99(4), 306–313 (2013).
   Google Scholar
• Stuhlinger MC , TsaoPS, HerJH, KimotoM, BalintRF, CookeJP. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation104(21), 2569–2575 (2001).
   PubMed Web of Science ®Google Scholar
• Cayatte AJ , PalacinoJJ, HortenK, CohenRA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb.14(5), 753–759 (1994).
   PubMedGoogle Scholar